AccelBio is a pharmaceutical contract research organization (CRO) and diagnostic testing development and point-of-care services company. We provide actionable results for biotechnology programs and pharmaceutical research and discovery with a focus on customized RNA and neurobiology research. With our expertise in molecular cell biology and animal work, we leverage premier bioassays in multiple formats, including high-throughput screens using chemically unique entities for drug discovery. Currently we are applying our RNA expertise to develop novel, rapid high-throughput Viral RNA diagnostic platforms for COVID-19 detection globally. Our contract services enable the highest quality R&D focused on genetic models and disease pathways. White-glove COVID-19 and other pathogen screening services.
View Top Employees from AccelBio| Website | http://www.accelbio.com |
| Revenue | $4 million |
| Employees | 3 (2 on RocketReach) |
| Address | 49 W 38th St 11TH Fl, New York, New York 10018, US |
| Phone | (718) 845-7374 |
| Fax | (212) 302-6141 |
| Technologies |
JavaScript,
HTML,
Twitter
+8 more
(view full list)
|
| Industry | Biotechnology, Business Services General, Business Services |
| Competitors | AgeX Therapeutics, Inc., BioLife Valley, HumanZyme, Inc |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies |
Looking for a particular AccelBio employee's phone or email?
AccelBio Questions
The AccelBio annual revenue was $4 million in 2024.
Jason Dictenberg is the Chief Executive Officer and Chairman of AccelBio.
2 people are employed at AccelBio.
AccelBio is based in New York, New York.
The NAICS codes for AccelBio are [54171, 54, 541714, 5417, 541].
The SIC codes for AccelBio are [873, 87].
Top AccelBio Employees
-
33
-
31
Related Companies
